The balance between toxic versus nontoxic microRNAs determines platinum sensitivity in ovarian cancer
M. Patel, Y. Wang, E. Bartom, R. Dhir, K. Nephew, D. Matei, A. Murmann, E. Lengyel, M. E. Peter
Abstract
Numerous micro(mi)RNAs (short noncoding RNAs that negatively regulate gene expression) have been linked to platinum (Pt) sensitivity and resistance in ovarian cancer (OC). miRNA activity occurs when the guide strand of the miRNA, with its seed sequence (pos. 2-7/8), is loaded into the RNA induced silencing complex (RISC) and targets complementary short seed matches in the 3 untranslated region of mRNAs. Toxic seeds, targeting genes critical for cancer cell survival, have been found in tumor suppressive miRNAs. Many si- and shRNAs can also kill cancer cells via toxic seeds, the most toxic carrying G-rich 6mer seed sequences. We now show that treatment of OC cells with Pt leads to an increase in RISC-bound miRNAs carrying toxic 6mer seeds and a decrease in miRNAs with nontoxic seeds. Pt-resistant cells did not exhibit this toxicity shift but retained sensitivity to cell death mediated by siRNAs carrying toxic 6mer seeds. Analysis of RISC-bound miRNAs in OC patients revealed that the ratio between miRNAs with toxic versus miRNAs with nontoxic seeds was predictive of treatment outcome. Application of the 6mer seed toxicity concept to cancer relevant miRNAs provides a new framework for understanding and predicting cancer therapy responses.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The miR-221-5p/RAD18/RAD51 axis regulates DNA damage tolerance and homologous recombination to drive platinum resistance in ovarian cancer.
Tasmin Rahman Omy, Naresh Sah, … Komaraiah Palle·bioRxiv·May 14, 2026
- The significance of microRNA genes expression in ovarian cancer cell lines resistant to cytotoxic drugs
D. Kazmierczak, K. Jopek, … R. Januchowski·bioRxiv·Dec 4, 2019
- Secreted soluble factors from tumor-activated mesenchymal stromal cells confer platinum chemoresistance to ovarian cancer cells
Y. Koren Carmi, R. Adawi, … J. Mahajna·bioRxiv·Feb 24, 2023
- Platinum-Induced Mitochondrial OXPHOS Contributes to Cancer Stem Cell Enrichment in Ovarian Cancer
S. Sriramkumar, R. Sood, … H. M. OHagan·Journal of Translational MedicinePeer-reviewed·May 31, 2022
- Ascites in malignant ovarian cancer confer ovarian cancer cells chemoresistance to platinum. Combination treatment with crizotinib and 2-hydroxyestradiol restores platinum sensitivity.
Y. K. Carmi, A. Agbarya, … J. Mahajna·bioRxiv·Sep 24, 2023
- 6mer seed toxicity in tumor suppressive microRNAs
Q. Q. Gao, W. E. Putzbach, … M. E. Peter·bioRxiv·Aug 31, 2018